MMP9 and chronic obstructive pulmonary disease: MMP9/TIMP1 ratio, as a well-known marker in smokers and COPD patients, was not altered after LPS exposure compared with DMEM, but CSC treatment induced a 1.6-fold increased expression compared with DMSO (Fig. 6(b, b’)).